Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vic Hasselblad

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Journal of the American College of Cardiology|February 27, 2010
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge scoreChristopher M O'Connor, Vic Hasselblad, Rajendra H Mehta, et al.
The Journal of Clinical Psychiatry|June 13, 2014
Pharmacologic and behavioral interventions to improve cardiovascular risk factors in adults with serious mental illness: a systematic review and meta-analysisJennifer M Gierisch, Jason A Nieuwsma, Daniel W Bradford, et al.
The Journal of Invasive Cardiology|January 5, 2008
Effectiveness of Glycerol Mono-oleate as a BiosealantGeorge L Adams, Roberto J Manson, Dana M Giangiacomo, et al.
Journal of the American College of Cardiology|June 11, 2013
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure)Stephen S Gottlieb, Amanda Stebbins, Adriaan A Voors, et al.
Journal of Cardiac Failure|March 7, 2007
Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trialLaura M Yamokoski, Vic Hasselblad, Debra K Moser, et al.
American Heart Journal|April 30, 2013
Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approachesSumeet Subherwal, E Magnus Ohman, Kenneth W Mahaffey, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
Journal of the American College of Cardiology|May 14, 2003
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)Christopher M O'Connor, Wendy A Gattis, Kirkwood F Adams, et al.
Chest|August 10, 2013
Evaluating cough assessment tools: a systematic reviewKristine M Schmit, Remy R Coeytaux, Adam P Goode, et al.
Journal of the American College of Cardiology|March 29, 2008
Cardiorenal interactions: insights from the ESCAPE trialAnju Nohria, Vic Hasselblad, Amanda Stebbins, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Journal of the American College of Cardiology|February 27, 2010
Triage after hospitalization with advanced heart failure: the ESCAPE (Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness) risk model and discharge scoreChristopher M O'Connor, Vic Hasselblad, Rajendra H Mehta, et al.
The Journal of Clinical Psychiatry|June 13, 2014
Pharmacologic and behavioral interventions to improve cardiovascular risk factors in adults with serious mental illness: a systematic review and meta-analysisJennifer M Gierisch, Jason A Nieuwsma, Daniel W Bradford, et al.
The Journal of Invasive Cardiology|January 5, 2008
Effectiveness of Glycerol Mono-oleate as a BiosealantGeorge L Adams, Roberto J Manson, Dana M Giangiacomo, et al.
Journal of the American College of Cardiology|June 11, 2013
Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure)Stephen S Gottlieb, Amanda Stebbins, Adriaan A Voors, et al.
Journal of Cardiac Failure|March 7, 2007
Prediction of rehospitalization and death in severe heart failure by physicians and nurses of the ESCAPE trialLaura M Yamokoski, Vic Hasselblad, Debra K Moser, et al.
American Heart Journal|April 30, 2013
Incorporation of bleeding as an element of the composite end point in clinical trials of antithrombotic therapies in patients with non-ST-segment elevation acute coronary syndrome: validity, pitfalls, and future approachesSumeet Subherwal, E Magnus Ohman, Kenneth W Mahaffey, et al.
Hypertension (Dallas, Tex. : 1979)|March 12, 2008
Pediatric antihypertensive trial failures: analysis of end points and dose rangeDaniel K Benjamin, P Brian Smith, Pravin Jadhav, et al.
Journal of the American College of Cardiology|May 14, 2003
Tezosentan in patients with acute heart failure and acute coronary syndromes: results of the Randomized Intravenous TeZosentan Study (RITZ-4)Christopher M O'Connor, Wendy A Gattis, Kirkwood F Adams, et al.
Chest|August 10, 2013
Evaluating cough assessment tools: a systematic reviewKristine M Schmit, Remy R Coeytaux, Adam P Goode, et al.
Journal of the American College of Cardiology|March 29, 2008
Cardiorenal interactions: insights from the ESCAPE trialAnju Nohria, Vic Hasselblad, Amanda Stebbins, et al.
Pageof 13